INSTITUT ZA ONKOLOGIJU

VOJVODINE
5th Serbian-French Novi Sad
Oncology Congress
21-22 March, 2014
Topic: Advanced Breast Cancer
ORGANIZING COMMITTEE
Prof. Dr Darjana Jovanovic,
Oncology Institute of Vojvodina, Serbia
Prof. Dr Jean-Pierre Lotz, Hpital Tenon, Assistance
Publique Hpitaux de Paris, France
Prof. Dr Milos Lucic,
Oncology Institute of Vojvodina, Serbia
Prof. Dr Dusan Jovanovic,
Oncology Institute of Vojvodina, Serbia
Prof. Dr Yazid Belkacemi,
Universit Paris-Est Crteil (UPEC),
Paris XII, France
Prof. Dr Slavica Knezevic-Usaj,
Oncology Institute of Vojvodina, Serbia
Prof. Dr Marko Erak,
Oncology Institute of Vojvodina, Serbia
Prof. Dr Milan Breberina,
Oncology Institute of Vojvodina, Serbia
Prof. Dr Andrija Golubovic,
Oncology Institute of Vojvodina, Serbia
Doc. Dr Ferenc Vicko,
Oncology Institute of Vojvodina, Serbia
Doc. Dr Aljosa Mandic,
Oncology Institute of Vojvodina, Serbia
Asist. Dr Lazar Popovic,
Oncology Institute of Vojvodina, Serbia
CONGRESS SECRETARIAT
Dr Tatjana Roganovic,
Oncology Institute of Vojvodina, Serbia
Dr Duanka Teanovic,
Oncology Institute of Vojvodina, Serbia
Dr Ivana Kolarov-Bjelobrk,
Oncology Institute of Vojvodina, Serbia
Dr Danijela Petkovic,
Oncology Institute of Vojvodina, Serbia
Dr Jelena Vukojevic,
Oncology Institute of Vojvodina, Serbia
Dr Vladimir Vidovic,
Oncology Institute of Vojvodina, Serbia
Dr Bojana Rimski,
Oncology Institute of Vojvodina, Serbia
Asist. Dr Branislav Djuran,
Oncology Institute of Vojvodina, Serbia
Asist. Dr Gorana Matovina-Brko,
Oncology Institute of Vojvodina, Serbia
Dr Nemanja Petrovi,
Oncology Institute of Vojvodina, Serbia
VENUE:
HOTEL Novi Sad,
Novi Sad, Serbia
REGISTRATION FEE:
3000,00 RSD
30 EUR
APLICATIONS FOR THE CONGRESS AND HOTEL ACCOMMO DATION
PANACOMP, Novi Sad
Phone Numbers: +381 21 466 075
+381 21 466 076
CONTACT PERSON:
Jadranka Petrovi (Technical Organiser)
Cell phone: + 381 63 549 317 E-mail: info@panacomp.net
http://www.panacomp.net
OFFICIAL LANGUAGE: English
http://www.onk.ns.ac.rs/novosti.htm
NSOC 2014.
FRENCH-SERBIAN
ONCOLOGICAL SOCIETY

5TH SERBIAN-FRENCH NOVI SAD
ONCOLOGY CONGRESS
21-22 MARCH, 2014
TOPIC: ADVANCED BREAST CANCER
FRIDAY MARCH 21, 2014
08.00-17.00 Registration
08.30 Opening ceremony
09.00-09.50 Morning session:
Locally advanced breast cancer
09.00-09.20 Prof. Dr Yann Delpech, Paris, France
09.20-09.50 Prof. Dr Maurice Mimoun, Paris, France
09.50-11.30 Morning Session:
Role of surgery in metastatic
breast cancer
09.50-10.10 Breast surgery in metastatic breast
cancer patient Doc. Dr Ferenc Vicko,
S. Kamenica, Serbia
10.10-10.40 Surgery for breast cancer visceral
metastases Prof. Francois Guillemin,
Nancy France
10.40-11.10 Surgery for breast cancer bone
metastases Prof. Dr Thierry Judet,
Paris, France
11.10-11-30 Discussion
11.30-12.30 ROCHE Satellite Symposium
12.30-14.00 Lunch Break
14.00-18.00 Afternoon session: Medical Oncology
14.00-14.20 When to re-biopsy a patient?
Which impact? Dr Martine Antoine,
Paris, France
14.20-14.40 Therapy for metastatic triple negative
breast cancer Dr Jasna Pesic,
S. Kamenica, Serbia
14.40-15.00 Treatment fo Her2-positive metastatic
breast cancer patient
Prof. Dr Jasna Trifunovic,
S. Kamenica, Serbia
15.00-15.20 How to treat asymptomatic ER-positive,
Her2-negative breast cancer patient
Dr Suzana Vasovic, Belgrade, Serbia
15.30-16.00 GLAXO SMITH KLINE Satellite Symposium
16.00-16.30 Coffee Break
16.30-16.50 New targeted therapy for metastatic
breast cancer Dr Ljiljana Stamatovic,
Belgrade, Serbia
16.50-17.10 Treatment for breast cancer CNS
metastases Dr Dusica Stojanovic, Nis, Serbia
17.10-17.30 Role of radiation therapy in oligometastastic
breast carcinomas Dr Francoise Pene,
Paris, France
17.30-17.50 Can we cure a patient with metastatic breast
cancer? DR Dragutin Donat,
S. Kamenica, Serbia
17.50 Conclusion Prof. Dr Jean-Pierre Lotz,
Paris, France
SATURDAY MARCH 22, 2014
09.00-11.00 Arome Session
09.00-09.45 A systems biology framework for understanding
response and resistance to cancer therapies
Prof. Dr Yosef Yarden, Rehovot, Israel
09.45-10.15 Emerging concepts of breast cancer
radiotherapy: tailoring strategy to tumor biology
Dr Pelagia Tsoutsou, Lausanne, Switzerland
10.15-10.45 Is there a role for loco-regional treatment of
the primary tumor in metastatic breast cancer?
Prof. DR Abraham Kuten, Haifa, Israel
10.45-11.00 Discussion
11.00-12.15 Young doctors/students session
11.00-11.15 Pain magement Dr Ana Cvetanovic
Nis, Serbia
11.15-11.30 Anti-Emesis Support Aleksandra Vejnovic
Novi Sad, Serbia
11.30-11.45 Supportive care during radiotherapy
Dr Milana Mitric S. Kamenica, Serbia
11.45-12.00 Haematopoietic support (G-CSF)
Vadim Afanassiev Paris, France
12.00-12.15 Haematopoietic support (EPO)
Sandra Assoun Paris, France

Discussion and NSOC
young students award
CONCLUSION
FRENCH-SERBIAN
ONCOLOGICAL SOCIETY